[1] Moutil A,Reddihough D,Marraffa C,et al.Fluoxetine for Autistic Behaviors ( FAB trial ):study protocol for a randomized controlled trial in children and adolescents with autism[J].Trials,2014,15(2):230. [2] Williams K,Brignell A,Randall M,et,al.Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders ( ASD ) [J].The Cochrane Library,2013,8.CD004677.doi:10.1002114651858.CD004677.pub3. [3] Langworthy-Lam KS,Aman MG,Van Bourgondien ME.Prevalence and patterns of use of psychoactive autism society of North Carolina[J].J Child Adolesc Psychopharmacol,2002,12(4):311-321. [4] Oswald D,Sonenklar N.Medication use among children with autism spectrum disorder[J].J Child Adolesc Psychopharmacol,2007,17(4):348-355. [5] Andersen SL.Trajectories of brain development:point of vulnerability or window of opportunity?[J].Neurosci Biobehav Rev,2003,27(1):3-18. [6] Karpova NN,Lindholm J,Pruunsild P,et al.Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice[J].Eur Neuropsychopharmacol.2009,19(1):97-108. [7] Daubert EA,Condron BG.Serotonin:a regulator of neuronal morphology and circuitry[J].Trends Neurosci,2010,33:424-434. [8] Zimmerberg B,Germeyan SC.Effects of neonatal fluoxetine exposure on behavior across development in rats selectively bred for an infantile affective trait[J].Dev Psychobiol,2015,57(2):141-152. [9] Wong RY,Oxendine SE,Godwin J.Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment[J].BMC Genomics,2013,14(1):348. [10] Kalueff AV,Stewart AM,Gerlai R.Zebrafish as an emerging model for studying complex brain disorders[J].Trends Pharmacol Sci,2014,35(1):63-75. [11] Schnrr SJ,Steenbergen PJ,Richardson MK,et al.Measuring thigmotaxis in larval zebrafish[J].Behav Brain Res,2012,228(4):367-374. [12] Olivier JD,Akerud H,Kaihola H,et al.The social zebrafish:Behavioral responses to conspecific,heterospecific,and computer animated fish[J].Behav Brain Res,2008,191(1):77-87. [13] Oliveira RF.Mind the fish:zebrafish as a model in cognitive social neuroscience [J].Front Neural Circuits,2013,7(1):131. [14] Engeszer RE,Ryan MJ,Parichy DM.Learned social preference in zebrafish[J].Curr Biol,2004,14(8):881-884. [15] Buske C,Gerlai R.Shoaling develops with age in zebrafish (Danio rerio) [J].Prog NeuroPsychopharm Biol Psych,2011,35(12):1409-1415. [16] Olivier JD,Valles A,Heesch F,et al.Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring[J].Psychopharmacology (Berl),2011,217:419-432. [17] Rodriguez-Porcel F,Green D,Khatri N,et al.Neonatal exposure of rats to antidepressants affects behavioral reactions to novelty and social interactions in a manner analogous to autistic spectrum disorders[J].Anat Rec (Hoboken),2011,294(12):1726-1735. [18] Alwan S,Friedman J.Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy[J].CNS Drugs,2009,23:493-509. [19] Bock N,Quentin DJ,Moll G,et,al.Very early treatment with fluoxetine and reboxetine causing long-lasting change of the serotonin but not the noradrenaline transporter in the frontal cortex of rats[J].World J Biol Psychiatry,2005,6(2):107-112. [20] Booij L,Tremblay RE,Szyf M,et,al.Genetic and early environmental influences on the serotonin system?:consequences for brain development and risk for psychopathology[J].J Psychiatry Neurosci,2015,40(1):5-18. [21] McDougle CJ,Naylor ST,Cohen DJ,et al.EFfects of tryptophan depletion in drug-free adults with autistic disorder[J].Arch Gen Psychiatry,1996,53(9):993-1000. [22] Sugie Y,Sugie H,Fukuda T,et al.Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism[J].J Autism Dev Disord,2005,35(4):377-385. [23] Croen LA,Grether JK,Yoshida CK,et al.Antidepressant use during pregnancy and childhood autism spectrum disorders[J].Arch Gen Psychiatry,2011,68(11):1104-1112. |